185 related articles for article (PubMed ID: 38189295)
1. Endocrine-disrupting chemicals and epigenetic reprogramming in developmental origin of uterine fibroids.
Yang Q; Ali M; Bariani MV; Vafaei S; Al-Hendy A
Sci Prog; 2023; 106(4):368504231215601. PubMed ID: 38189295
[TBL] [Abstract][Full Text] [Related]
2. Developmental reprogramming of myometrial stem cells by endocrine disruptor linking to risk of uterine fibroids.
Yang Q; Ali M; Treviño LS; Mas A; Al-Hendy A
Cell Mol Life Sci; 2023 Aug; 80(9):274. PubMed ID: 37650943
[TBL] [Abstract][Full Text] [Related]
3. TGFβ signaling links early life endocrine-disrupting chemicals exposure to suppression of nucleotide excision repair in rat myometrial stem cells.
Bariani MV; Cui YH; Ali M; Bai T; Grimm SL; Coarfa C; Walker CL; He YY; Yang Q; Al-Hendy A
Cell Mol Life Sci; 2023 Sep; 80(10):288. PubMed ID: 37689587
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic Modulation of Inflammatory Pathways in Myometrial Stem Cells and Risk of Uterine Fibroids.
Yang Q; Ali M; Treviño LS; Mas A; Ismail N; Al-Hendy A
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511399
[TBL] [Abstract][Full Text] [Related]
5. Endocrine-disrupting chemicals and uterine fibroids.
Katz TA; Yang Q; Treviño LS; Walker CL; Al-Hendy A
Fertil Steril; 2016 Sep; 106(4):967-77. PubMed ID: 27553264
[TBL] [Abstract][Full Text] [Related]
6. Minireview: Epigenomic Plasticity and Vulnerability to EDC Exposures.
Walker CL
Mol Endocrinol; 2016 Aug; 30(8):848-55. PubMed ID: 27355193
[TBL] [Abstract][Full Text] [Related]
7. Linking inter-individual variability to endocrine disruptors: insights for epigenetic inheritance.
Latchney SE; Fields AM; Susiarjo M
Mamm Genome; 2018 Feb; 29(1-2):141-152. PubMed ID: 29218402
[TBL] [Abstract][Full Text] [Related]
8. The role of endocrine-disrupting chemicals in uterine fibroid pathogenesis.
Bariani MV; Rangaswamy R; Siblini H; Yang Q; Al-Hendy A; Zota AR
Curr Opin Endocrinol Diabetes Obes; 2020 Dec; 27(6):380-387. PubMed ID: 33044243
[TBL] [Abstract][Full Text] [Related]
9. Epigenomic and enhancer dysregulation in uterine leiomyomas.
Mlodawska OW; Saini P; Parker JB; Wei JJ; Bulun SE; Simon MA; Chakravarti D
Hum Reprod Update; 2022 Jun; 28(4):518-547. PubMed ID: 35199155
[TBL] [Abstract][Full Text] [Related]
10. Developmental exposure to endocrine disrupting chemicals alters the epigenome: Identification of reprogrammed targets.
Prusinski L; Al-Hendy A; Yang Q
Gynecol Obstet Res; 2016 Jul; 3(1):1-6. PubMed ID: 27478869
[TBL] [Abstract][Full Text] [Related]
11. Endocrine disruptor exposure during development increases incidence of uterine fibroids by altering DNA repair in myometrial stem cells.
Prusinski Fernung LE; Yang Q; Sakamuro D; Kumari A; Mas A; Al-Hendy A
Biol Reprod; 2018 Oct; 99(4):735-748. PubMed ID: 29688260
[TBL] [Abstract][Full Text] [Related]
12. Transgenerational epigenetic effects from male exposure to endocrine-disrupting compounds: a systematic review on research in mammals.
Van Cauwenbergh O; Di Serafino A; Tytgat J; Soubry A
Clin Epigenetics; 2020 May; 12(1):65. PubMed ID: 32398147
[TBL] [Abstract][Full Text] [Related]
13. The Role of Epigenetics in the Latent Effects of Early Life Exposure to Obesogenic Endocrine Disrupting Chemicals.
Stel J; Legler J
Endocrinology; 2015 Oct; 156(10):3466-72. PubMed ID: 26241072
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D3 Ameliorates DNA Damage Caused by Developmental Exposure to Endocrine Disruptors in the Uterine Myometrial Stem Cells of Eker Rats.
Elkafas H; Ali M; Elmorsy E; Kamel R; Thompson WE; Badary O; Al-Hendy A; Yang Q
Cells; 2020 Jun; 9(6):. PubMed ID: 32545544
[TBL] [Abstract][Full Text] [Related]
15. Multigenerational and transgenerational effects of endocrine disrupting chemicals: A role for altered epigenetic regulation?
Xin F; Susiarjo M; Bartolomei MS
Semin Cell Dev Biol; 2015 Jul; 43():66-75. PubMed ID: 26026600
[TBL] [Abstract][Full Text] [Related]
16. Reprogramming of the Epigenome by MLL1 Links Early-Life Environmental Exposures to Prostate Cancer Risk.
Wang Q; Trevino LS; Wong RL; Medvedovic M; Chen J; Ho SM; Shen J; Foulds CE; Coarfa C; O'Malley BW; Shilatifard A; Walker CL
Mol Endocrinol; 2016 Aug; 30(8):856-71. PubMed ID: 27219490
[TBL] [Abstract][Full Text] [Related]
17. Endocrine-Disrupting Chemicals and Vitamin D Deficiency in the Pathogenesis of Uterine Fibroids.
Elkafas H; Badary O; Elmorsy E; Kamel R; Yang Q; Al-Hendy A
J Adv Pharm Res; 2021; 5(2):260-275. PubMed ID: 34746367
[TBL] [Abstract][Full Text] [Related]
18. An epigenome-wide association study identifies multiple DNA methylation markers of exposure to endocrine disruptors.
Lu X; Fraszczyk E; van der Meer TP; van Faassen M; Bloks VW; Kema IP; van Beek AP; Li S; Franke L; Westra HJ; ; Xu X; Huo X; Snieder H; Wolffenbuttel BHR; van Vliet-Ostaptchouk JV
Environ Int; 2020 Nov; 144():106016. PubMed ID: 32916427
[TBL] [Abstract][Full Text] [Related]
19. Epigenomic disruption: the effects of early developmental exposures.
Bernal AJ; Jirtle RL
Birth Defects Res A Clin Mol Teratol; 2010 Oct; 88(10):938-44. PubMed ID: 20568270
[TBL] [Abstract][Full Text] [Related]
20. Environmental epigenomics: Current approaches to assess epigenetic effects of endocrine disrupting compounds (EDC's) on human health.
Tapia-Orozco N; Santiago-Toledo G; Barrón V; Espinosa-García AM; García-García JA; García-Arrazola R
Environ Toxicol Pharmacol; 2017 Apr; 51():94-99. PubMed ID: 28215500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
